Analyst Ratings for Emergent BioSolutions (EBS)
EBS Rating Summary
EBS Price Target Summary
- Highest: $12.00 (StoneX)
- Lowest: $10.00 (H.C. Wainwright)
- Average: $11.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.00 (+76.8%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$11.00 (+76.8%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | JPMorgan | Jessica Fye | New Coverage | Underweight (N/A) |
N/A (N/A) |
4.89 (6.22) |
27.2% | Details |
| 12/30/2024 | H.C. Wainwright » Updated 8/10/2026 |
Raghuram Selvaraju | New Coverage | Buy (N/A) |
10.00 (12.00) |
8.27 (6.22) |
-24.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
